Inventor

SHEPARD H MICHAEL

US59 patents

⚠️ This page may combine multiple inventors who share the name “SHEPARD H MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SHEPARD H MICHAEL

HALOZYME INC

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

Combination therapy with an anti-hyaluronan agent and therapeutic agent

PH20 polypeptide variants with a modification at position 324 of the PH20 polypeptide and a method of making thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants, formulations and uses thereof

Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same

GENENTECH INC

Monoclonal antibodies directed to the HER2 receptor

Monoclonal antibodies directed to the HER2 receptor

Monoclonal antibodies directed to the HER2 receptor

Monoclonal antibodies directed to the HER2 receptor

Monoclonal antibodies directed to the her2 receptor

Monoclonal antibodies directed to the HER2 receptor

Monoclonal antibodies directed to the HER2 receptor

HER2 extracellular domain

HER2 extracellular domain

Use of tumor necrosis factor (TNF) as an adjuvant

NEWBIOTICS INC

Enzyme catalyzed therapeutic agents

Enzyme catalyzed therapeutic agents

Methods and compositions for overcoming resistance to biologic and chemotherapy

Enzyme catalyzed therapeutic activation

Application of enzyme prodrugs as anti-infective agents

CELMED ONCOLOGY USA INC

Methods for treating therapy-resistant tumors

Phosphoramidate compounds and methods of use

Methods and compositions for overcoming resistance to biologic and chemotherapy

Methods to treat autoimmune and inflammatory conditions

Enzyme catalyzed therapeutic agents

CANJI INC

Method of purification of viral vectors

Methods for selectively transducing pathologic mammalian cells using a tumor suppressor gene

WEI GE

PH20 polypeptide variants, formulations and uses thereof

UNIV NORTHWESTERN

Method and compositions for modulating neovascularization

JIANG PING

Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

MANEVAL DANIEL C

Combination therapy with an anti-hyaluronan agent and therapeutic agent

GENZYME CORP

Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy

UNIV CALIFORNIA

Therapeutic use of the retinoblastoma susceptibility gene product

SHEPARD H MICHAEL

Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods